Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s display version rather than the underlying study record content.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 to reflect the latest site version.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; a minor administrative update with no changes to study content or user-facing information.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision v3.4.1 removed and v3.4.2 added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.